Expert Opinion on Investigational Drugs (ERA Journal)

Expert Opinion on Investigational Drugs is an ERA accredited research journal used as part of the evaluation of the ERA research rankings.

Expert Opinion on Investigational Drugs issns are issn1: 1354-3784 issn2: 1744-7658.

The field covered by Expert Opinion on Investigational Drugs as part of the evaluation of Australian university research excellence is:

Pharmacology and Pharmaceutical Sciences Research Rankings (Sub-Field)

Other ERA-accredited journals supporting the evaluation of the Pharmacology and Pharmaceutical Sciences field include:

- COPD: Journal of Chronic Obstructive Pulmonary Disease
- Diabetes and Vascular Disease Research
- Expert Review of Pharmacoeconomics and Outcomes Research: informing decision-making in the delivery of cost-effective healthcare
- Immunotherapy
- International Immunopharmacology
- International Journal of Pharmaceutics
- Journal of Anaesthesiology Clinical Pharmacology
- Journal of Applied Toxicology
- Journal of Clinical Problem-Based Learning
- Journal of Public Health Pharmacy
- Molecular Cancer Therapeutics
- NeuroMolecular Medicine
- Redox Report
- Toxins
- Vitamins and Hormones: Advances in Research and Applications

ERA Research Rankings Submenu

- ERA 2018 Outcomes Research Rankings List

- ERA 2018 Research Rankings Analysis

- ERA 2018 Individual University Outcomes List

- ERA List of Research Fields Rankings

- ERA Journal Rankings 2018 List

Latest News and Updates:

- Top 10 Best Australian Universities

- Gender Balance Male-Female Ratio

- ERA 2018 Outcomes Research Rankings List

- University Bachelor Degree Completion Rates

- QS Employability Rankings Australian Universities

- ARWU World Rankings of Australian Universities

- Group of Eight (go8) World Rankings

Share This Page